RxDoctor Payments Data

Bo Lu, MD

Radiation Oncology · Columbia, MONPI 1245314343

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $977 of the $1,212 with a category attached, or 80.6%. 8 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 59.5% of the total. Reporting peaked in 2023 at $616 and has fallen 98.0% since, to $12 in 2025.

$1,212in general payments, 2019–2025

Across 24 payments — averaging $50.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$721
  • E.r. Squibb & Sons, L.L.C.$150
  • Roche Diagnostics Corporation$118
  • Merck$70
  • AstraZeneca$67
  • Visionrt, Inc.$33
  • plus $53 from 2 others
$46,544in research payments, 2019–2025

Across 3 payments — averaging $15,515 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$44K
  • Merck$2K

What the payments were for

  • Travel & lodging$23519%
  • Food & beverage$97781%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,212 in reported general payments places this provider in the 55th percentile of 123 radiation oncology providers in Missouri.

See all radiation oncology providers in Missouri

Medicare billing

Part B allowed, 2024
$17,055
Medicare patients
35
Services billed
144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →